Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Radvax |
| Synonyms | |
| Therapy Description |
Radvax is an autologous tumor vaccine comprising a patient-derived tumor cell lysate and polysaccharide-derived adjuvant, which potentially induces an enhanced antitumor immune response (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Radvax | Autologous Tumor Vaccine Plus Polysaccharide-derived Delta Inulin Adjuvant | Radvax is an autologous tumor vaccine comprising a patient-derived tumor cell lysate and polysaccharide-derived adjuvant, which potentially induces an enhanced antitumor immune response (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05807035 | Phase I | Radvax | Autologous Tumour Vaccine Trial | Recruiting | AUS | 0 |